Annotation-Euglena-Enzymes | | | 0 | | Shuichi Kawashima | 2016-06-13 | Developing | |
ASCO_abstracts | | asco abstracts sample dataset | 28 K | | alo33 | 2023-11-29 | Testing | |
AxD_symptoms | | Symptoms of AxD from available case report and case series | 401 | | Eisuke Dohi | 2023-11-29 | Developing | |
bayaba | | nalee | 7 | | Nakyolee | 2023-11-29 | | |
bc2gn_test | | test | 0 | | | 2021-07-13 | Testing | |
BioASQ-sample | | collection of PubMed articles which appear in the BioASQ sample data set. | 0 | BioASQ | Jin-Dong Kim | 2023-11-28 | Testing | |
Bioinformatics_fulltext | | | 0 | | Sophie Nam | 2023-11-28 | Uploading | |
BioLarkPubmedHPO | | 228 abstracts manually annotated with Human Phenotype Ontology (HPO) concepts and harmonized by three curators, which can be used as a reference standard for free text annotation of human phenotypes. For more info, please see Groza et al. "Automatic concept recognition using the human phenotype ontology reference and test suite corpora", 2015. | 7.16 K | Tudor Groza | simon | 2023-11-29 | Released | |
biomarkers | | IL/TNF biomarkers | 857 K | | alo33 | 2023-11-24 | | |
BioMedLAT | | Annotation of 643 questions from BioASQ with the Lexical Answer Type (LAT) and headword. | 0 | | | 2016-09-23 | Developing | |
BioNLP16_DUT | | | 6.5 K | | Messiy | 2023-11-29 | Testing | |
BioNLP16_Messiy | | | 6.5 K | | Messiy | 2023-11-29 | Testing | |
bionlp-ost-19-BB-kb-dev | | | 1.89 K | | ldeleger | 2023-11-26 | Developing | |
bionlp-ost-19-BB-kb-ner-dev | | | 1.9 K | | ldeleger | 2023-11-29 | Developing | |
bionlp-ost-19-BB-kb-ner-test | | | 125 | | ldeleger | 2023-11-28 | Developing | |
bionlp-ost-19-BB-kb-ner-train | | | 3.56 K | | ldeleger | 2023-11-28 | Developing | |
bionlp-ost-19-BB-kb-test | | | 2.04 K | | ldeleger | 2023-11-29 | Developing | |
bionlp-ost-19-BB-kb-train | | | 3.45 K | | ldeleger | 2023-11-26 | Developing | |
bionlp-ost-19-BB-norm-dev | | | 1.33 K | | ldeleger | 2023-11-29 | Developing | |
bionlp-ost-19-BB-norm-ner-dev | | | 1.33 K | | ldeleger | 2023-11-27 | Developing | |